Sunesis Pharmaceutic (SNSS) Stock Price, Quote, News and Overview

What is the stock price of Sunesis Pharmaceutic today?

The current stock price of SNSS is 5.32 null. The price increased by 24.3% in the last trading session.

What is the ticker symbol for Sunesis Pharmaceutic stock?

The exchange symbol of Sunesis Pharmaceutic is SNSS and it is listed on the Nasdaq exchange.

On which exchange is SNSS stock listed?

SNSS stock is listed on the Nasdaq exchange.

What is Sunesis Pharmaceutic worth?

Sunesis Pharmaceutic (SNSS) has a market capitalization of 96.25M null. This makes SNSS a Micro Cap stock.

What are the support and resistance levels for Sunesis Pharmaceutic (SNSS) stock?

Sunesis Pharmaceutic (SNSS) has a support level at 2.87. Check the full technical report for a detailed analysis of SNSS support and resistance levels.

Should I buy Sunesis Pharmaceutic (SNSS) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of SNSS, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of SNSS, evaluating the profitability, health, valuation and growth aspects
• Sunesis Pharmaceutic (SNSS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• Sunesis Pharmaceutic (SNSS) Sales and EPS estimates to see what analysts future expectations are.
• Sunesis Pharmaceutic (SNSS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• Sunesis Pharmaceutic (SNSS) Insider and Institutional Ownership to learn about the owners and their transactions.
• Sunesis Pharmaceutic (SNSS) Stock Chart to make your own analysis
• Sunesis Pharmaceutic (SNSS) Latest news and press-releases to stay up to date.

Does Sunesis Pharmaceutic (SNSS) stock pay dividends?

SNSS does not pay a dividend.

What is the Price/Earnings (PE) ratio of Sunesis Pharmaceutic (SNSS)?

Sunesis Pharmaceutic (SNSS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.89).

ChartMill assigns a fundamental rating of 3 / 10 to SNSS. The financial health of SNSS is average, but there are quite some concerns on its profitability.

Over the last trailing twelve months SNSS reported a non-GAAP Earnings per Share(EPS) of -1.89. The EPS decreased by -7.39% compared to the year before.

ChartMill assigns a Buy % Consensus number of 73% to SNSS. The Buy consensus is the average rating of analysts ratings from 3 analysts.